Kidney Patients' hearts under study: can anemia drugs reverse damage?
NCT ID NCT07380893
First seen Feb 02, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This observational study will check how often left ventricular hypertrophy (thickening of the heart muscle) occurs in people with chronic kidney disease. It will also test whether erythropoietin, a drug used to treat anemia, can reduce that thickening. About 100 adults with advanced kidney disease and anemia will take part at Sohag University Hospital.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR HYPERTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.